ZA83640B - Ozone inactivated organisms as vaccines - Google Patents

Ozone inactivated organisms as vaccines

Info

Publication number: ZA83640B
Authority: ZA; South Africa
Prior art keywords: vaccines; ozone; inactivated; inactivated organisms; microorganism
Prior art date: 1982-02-09

Application number

ZA83640A

Other languages

English (en)

Inventor

Chung Zee Yuan

David C Bolton

Original Assignee

Univ California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-09

Filing date

1983-01-31

Publication date

1984-03-28

1983-01-31 Application filed by Univ California filed Critical Univ California

1984-03-28 Publication of ZA83640B publication Critical patent/ZA83640B/xx

Links

229960005486 vaccine Drugs 0.000 title abstract 3
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 title abstract 2
244000005700 microbiome Species 0.000 abstract 4
230000009851 immunogenic response Effects 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Microbiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ZA83640A 1982-02-09 1983-01-31 Ozone inactivated organisms as vaccines ZA83640B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US34856982A	1982-02-09	1982-02-09

Publications (1)

Publication Number	Publication Date
ZA83640B true ZA83640B (en)	1984-03-28

Family

ID=23368584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA83640A ZA83640B (en)	1982-02-09	1983-01-31	Ozone inactivated organisms as vaccines

Country Status (10)

Country	Link
EP (1)	EP0086071B1 (fr)
JP (1)	JPS58201721A (fr)
AT (1)	ATE16348T1 (fr)
AU (1)	AU558008B2 (fr)
CA (1)	CA1212320A (fr)
DE (1)	DE3361138D1 (fr)
DK (1)	DK52783A (fr)
IL (1)	IL67818A (fr)
NZ (1)	NZ203094A (fr)
ZA (1)	ZA83640B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3345864A1 (de) *	1983-12-19	1985-06-27	Egbert Frh. von 8000 München Malsen-Ponickau	Impfstoff und verfahren zu seiner herstellung
US4632980A (en) *	1985-04-03	1986-12-30	Immunologics	Ozone decontamination of blood and blood products
EP0227441B1 (fr) *	1985-12-20	1991-05-15	E.I. Du Pont De Nemours And Company	Préparation de comprimés contenant des substances microbiologiques
FR2603805A1 (fr) *	1986-09-16	1988-03-18	Transfusion Sanguine Assoc Rgl	Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
GB0603749D0 (en) *	2006-02-24	2006-04-05	Moving Sun Ltd	Immune system stimulant and process of manufacturing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE471250A (fr) *
CH173194A (de) *	1933-05-27	1934-11-15	Veterinaria A G Zuerich	Verfahren zur Herstellung eines Impfstoffes zur aktiven Immunisierung von Menschen oder Tieren gegen anaerobe Krankheitskeime.
CH200180A (de) *	1936-03-26	1938-09-30	Frei Walter Dr Prof	Verfahren zur Herstellung von Vaccinen.
GB1230414A (fr) *	1968-07-09	1971-05-05

1983
- 1983-01-26 NZ NZ203094A patent/NZ203094A/en unknown
- 1983-01-27 CA CA000420401A patent/CA1212320A/fr not_active Expired
- 1983-01-27 AU AU10812/83A patent/AU558008B2/en not_active Expired - Fee Related
- 1983-01-31 ZA ZA83640A patent/ZA83640B/xx unknown
- 1983-01-31 EP EP83300483A patent/EP0086071B1/fr not_active Expired
- 1983-01-31 AT AT83300483T patent/ATE16348T1/de not_active IP Right Cessation
- 1983-01-31 DE DE8383300483T patent/DE3361138D1/de not_active Expired
- 1983-02-01 IL IL67818A patent/IL67818A/xx unknown
- 1983-02-08 DK DK52783A patent/DK52783A/da not_active Application Discontinuation
- 1983-02-08 JP JP58018265A patent/JPS58201721A/ja active Pending

Also Published As

Publication number	Publication date
NZ203094A (en)	1986-04-11
DK52783D0 (da)	1983-02-08
EP0086071B1 (fr)	1985-11-06
ATE16348T1 (de)	1985-11-15
DE3361138D1 (en)	1985-12-12
CA1212320A (fr)	1986-10-07
AU1081283A (en)	1983-08-18
JPS58201721A (ja)	1983-11-24
AU558008B2 (en)	1987-01-15
IL67818A (en)	1987-03-31
IL67818A0 (en)	1983-06-15
DK52783A (da)	1983-08-10
EP0086071A1 (fr)	1983-08-17

Publication	Publication Date	Title
SG70978A1 (en)	2000-03-21	Urease-based vaccine against helicobacter infection
FR2475900B1 (fr)	1983-06-10
CA2134835A1 (fr)	1995-05-04	Vaccins de virulence attenuee administres in ovo
ES2092306T3 (es)	1996-11-16	Adyuvante para vacunas.
KR970009347B1 (en)	1997-06-10	Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
CH614718A5 (en)	1979-12-14	Process for the preparation of glucosamine derivatives
AU2152988A (en)	1989-03-02	Intranasal vaccination of horses with inactivated microorganisms or antigenic material
NZ287385A (en)	1998-10-28	Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
ES2244617T3 (es)	2005-12-16	Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
NZ192477A (en)	1983-02-15	Method for protecting dogs against virulent canine parvovirus using inactivated virus vaccine
DE3361138D1 (en)	1985-12-12	Ozone inactivated organisms as vaccines
GB8910570D0 (en)	1989-06-21	Acellular vaccine
AU2521792A (en)	1993-03-25	Chicken anaemia agent vaccine
EP0090660A3 (fr)	1983-11-23	Vaccin anti-gonococcique
EP0256792A3 (en)	1988-05-25	Vaccines for fowl colibacillosis
GB9018061D0 (en)	1990-10-03	Compositions for vaccines
EP0636030A4 (fr)	1996-02-07	VACCIN A BACTERINE ET A TOXOIDE A BASE DE -i(PASTEURELLA HAEMOLYTICA) DE TYPE A-1.
JPS5781417A (en)	1982-05-21	Human immunity effect imparting vaccine against escherichia coli infectious desease
JPS5287221A (en)	1977-07-20	Preventive for chicken dinfections
RU93005000A (ru)	1996-10-27	Композиция вакцин, способ ее получения, способ исключения иммунной реакции
EP0178928A3 (fr)	1987-11-19	Vaccins